| Date | Title | Description |
| 09.09.2026 | Encoded Therapeutics Inks $275 Million in Series F |
SOUTH SAN FRANCISCO, CA, Encoded Therapeutics, a clinical-stage biotechnology company, announced the close of a $275 million financing.
>> Click here for more funding data on Encoded Therapeutics
>> To export Encoded Therapeuti... |
| 27.08.2026 | Nvidia Could Acquire Hugging Face for $13 Billion | Set Trending Topics as a preferred source on Google.
Nvidia has agreed to acquire Hugging Face for $12.9 billion, The Information reported Wednesday evening, citing a source familiar with the matter. According to TechCrunch, however, no sig... |
| 25.08.2026 | LifeMine Therapeutics Secures Landmark Funding, Reshaping Transplant Medicine | LifeMine Therapeutics secured $263 million. This landmark funding fuels a revolution in organ transplant medicine. The company's lead asset, LIFE-001, offers a next-generation approach. It targets rejection without severe toxicities. Tradit... |
| 19.08.2026 | LifeMine Therapeutics Secures $263M Series D & E |
WATERTOWN, MA, LifeMine Therapeutics, a clinical-stage biopharmaceutical company, announced $263 million in financing.
>> Click here for more funding data on LifeMine Therapeutics
>> To export LifeMine Therapeutics funding data... |
| 13.08.2026 | Blacksmith raises $45 million at $550 million valuation as AI-generated code drives validation demand | Blacksmith, a cloud platform used to build and test software code, has raised $45 million in a Series B funding round led by Peak XV Partners, valuing the startup at $550 million.
Advertisment
Existing investors Y Combinator and GV also par... |
| 12.08.2026 | Blacksmith Raises $45M in Series B Funding | Blacksmith, a San Francisco, CA-based provider of a cloud platform for validating code, raised $45M in Series B funding, at $550M valuation
The round was led by Peak XV Partners with participation from existing investors Y Combinator and GV... |
| 12.08.2026 | Blacksmith Raises $45M to Scale AI Code Validation Cloud | Blacksmith Raises $45M Series B Funding
Blacksmith has raised $45 million in Series B funding at a $550 million valuation. Peak XV Partners led the round with participation from existing investors Y Combinator and GV. The latest financing b... |
| 07.08.2026 | Obsidian Security Nabs $85M to Secure AI's New Frontier | Obsidian Security secured $85 million in Series D funding. This investment propels its leading platform. It protects non-human identities and AI agents. These autonomous systems pose new cybersecurity challenges. They access sensitive data ... |
| 07.08.2026 | LifeMine Therapeutics Raises $263M in Funding | LifeMine Therapeutics Inc., a Watertown, MA-based clinical-stage biopharmaceutical company leveraging digital genomics research technology, has raised $263M in funding.
The round included a $188M Series E financing led by Milky Way Investme... |
| 06.08.2026 | Venture Capital & Startup Funding Roundup, August 6, 2026: Bessemer Venture Partners, Gates Frontier, General Atlantic, Google Ventures, Gradient Ventures, Menlo Ventures, Y Combinator & More | The sprint of venture rounds today underscores a clear theme: autonomy and AI are pulling massive capital — both in the physical world and online. In defense and logistics, startups like Hadrian and Moove drew eye-popping checks ($1.37 bill... |
| 04.08.2026 | Obsidian Raises $85M in Series D Funding | Obsidian Security, a Palo Alto, CA-based provider of a platform securing non-human identities and AI agents across third-party applications, raised $85M in Series D financing.
The round was led by Crescent Cove Advisors with participation f... |
| 03.08.2026 | Meet the coaches, measurers, and builders carving out a slice of the AI cost-saving business | Don't use Swiss Army knives for surgically precise work; use scalpels.
That's what Manos Koukoumidis and other players in the AI cost-saving business say is the biggest problem with how companies use AI. They're using the most powerful, ver... |
| 28.07.2026 | Latest Harambeans cohort open for applications | The Harambeans, who were founded in 2008, identify as “visionaries transforming Africa’s challenges into opportunities” and an “alliance of determined entrepreneurs who are building Africa’s future.”
In the past ten years, Harambeans has gi... |
| 27.07.2026 | Ilya Sutskever’s Safe Superintelligence gets access to Nvidia’s Vera Rubin platform | Safe Superintelligence Inc., a frontier lab that’s trying to develop safe and ethically-aligned artificial superintelligence for the benefit of humanity, has hit the headlines again after striking a significant deal with Nvidia Corp. that w... |
| 18.07.2026 | Wonder Secures $650M; Food Tech Platform Valued at $9B | Wonder, a leading food technology platform, recently secured $650 million in Series D financing. This substantial investment pushes its pre-money valuation to $9 billion. The new capital will accelerate Wonder's aggressive expansion strateg... |
| 17.07.2026 | Fireworks AI Ignites Enterprise AI with $1.5 Billion Funding | Fireworks AI just secured $1.5 billion in Series D funding, now valued at $17.5 billion. This capital injection accelerates global compute infrastructure and engineering expansion. The platform empowers enterprises to develop and deploy spe... |
| 16.07.2026 | Venture capital & startup funding roundup, July 16, 2026: 8VC, Accel, ARK Invest, GV, Khosla Ventures, Mark Cuban, and Sequoia Capital, | Venture capital continues to reward startups building the infrastructure behind AI, automation, cybersecurity, and enterprise software. The last 12 hours of startup financing did not look like a broad reopening of venture capital. They look... |
| 16.07.2026 | Wonder Raises $650M Series D, at $9 Billion Valuation | Wonder, a NYC-based provider of a food technology platform, raised $650M in Series D funding, at $9 Billion valuation.
Backers included Accel, GV, New Enterprise Associates, AllianceBernstein, ARK Invest and Kayne Anderson Rudnick Investmen... |
| 16.07.2026 | Wonder Raises $650 Million Series D At $9 Billion Valuation To Accelerate Food Tech Platform Expansion | Wonder, a vertically integrated food technology platform founded by Marc Lore, has raised $650 million in a Series D round at a $9 billion pre-money valuation. Existing investors Accel, GV (Google Ventures), and New Enterprise Associates pa... |
| 16.07.2026 | Wonder Pulls In $650M Series D Financing |
NEW YORK, NY, Wonder, a leading food technology platform, today announced its $650 million Series D round at a pre-money valuation of $9 billion.
>> Click here for more funding data on Wonder
>> To export Wonder funding data to... |
| 09.07.2026 | TailorMed and Tennr Announce Collaboration to Streamline Patient Medication Workflows | Collaboration connects referral automation and medication journey support for infusion centers, specialty pharmacies, and the patients they serve
NEW YORK, NY / ACCESS Newswire / July 9, 2026 / TailorMed, a leading medication success platfo... |
| 02.07.2026 | Oblenio Bio Secures $62M to Advance Autoimmune Immune Reset Therapy LBL-051 into Clinic | Oblenio Bio raised $62 million in Series B funding. Pfizer Ventures led the round, with Deep Track Capital and GV joining. Funds will advance LBL-051, a tri-specific T-cell engager, into clinical development. LBL-051 targets refractory auto... |
| 29.06.2026 | Nebex Raises $30M in Seed Funding | Nebex, a New York City-based space financial technology and transactional marketplace platform provider, raised $30m in seed funding.
The round was led by Google Ventures with participation from other investors.
The company intends to use t... |
| 29.06.2026 | Nebex Raises $30 Million Seed Round To Build Market Infrastructure For Space Economy | Nebex announced that it has raised $30 million in seed funding to build market infrastructure for the global space economy. The round was led by GV, with participation from other venture funds. Nebex also announced a banking relationship wi... |
| 27.06.2026 | Oblenio Bio Raises $62 Million Series B To Advance Autoimmune Disease Therapy | Oblenio Bio announced that it has closed an oversubscribed $62 million Series B financing round to advance its lead autoimmune disease program into clinical development. The round was led by Pfizer Ventures, with participation from new inve... |
| 25.06.2026 | Overture Life Launches Global ICSI.A Center of Excellence Program, Bringing the World’s First Automated ICSI into Clinical Use Across Five Leading Global Fertility Centers | Overture Life, the global leader in automated IVF and the first company to achieve live births from both robotic fertilization and robotic egg freezing, announced the launch of its ICSI.A Center of Excellence Program, with the first clinica... |
| 23.06.2026 | Verse Raises $54 Million Series B To Accelerate Energy Infrastructure For AI Data Centers | Verse announced that it has raised an oversubscribed $54 million Series B funding round led by Bessemer Venture Partners. GV, NVIDIA, Norrsken VC, and others also participated in the round. Verse is an energy infrastructure platform focused... |
| 21.06.2026 | Odyssey AI Secures $310M: A Leap in World Model Technology | AI lab Odyssey secured $310 million in Series B funding. Its valuation reached $1.45 billion. This investment fuels accelerated development of world models. These AI systems predict, simulate, and interact with physical environments over lo... |
| 21.06.2026 | AI Lab Odyssey Achieves $1.45 Billion Valuation in Landmark Funding Round | Odyssey, a vanguard in artificial intelligence, has secured a monumental $310 million in Series B funding. This investment propels its valuation to an impressive $1.45 billion. The Palo Alto-based lab is pioneering "world models."... |
| 21.06.2026 | Verse Raises $54 Million Series B To Accelerate Power Access For AI Data Centers | Verse announced that it has raised an oversubscribed $54 million Series B funding round. The round was led by Bessemer Venture Partners, with participation from GV, NVIDIA, Norrsken VC, and others.
Verse is an energy infrastructure platform... |
| 18.06.2026 | Odyssey Raises $310M in Series B Funding at $1.45 Billion Valuation | Odyssey, a Palo Alto, California-based developer of general world simulation models and physical artificial intelligence platforms, raised $310m in a Series B funding round at a $1.45 billion valuation.
The round was led by Natural Capital,... |
| 18.06.2026 | Verse Raises $54M in Series B Funding | Verse, a San Francisco, CA-based provider of an energy infrastructure platform for the AI economy, raised $54M in Series B funding.
The round was led by Bessemer Venture Partners with participation from GV, NVIDIA, Norrsken VC, and others.
... |
| 18.06.2026 | Odyssey Raises $310 Million at a $1.45 Billion Valuation | Odyssey is an innovative artificial intelligence lab dedicated to building advanced world models. By developing technology that allows AI to understand and simulate physical reality, Odyssey enables the creation of highly sophisticated, con... |
| 18.06.2026 | AI lab Odyssey valued at $1.45 billion in latest funding round | June 17 : AI lab Odyssey said on Wednesday it has raised $310 million in a funding round that valued it at $1.45 billion.
The Series B round was led by Natural Capital, with participation from Amazon, AMD Ventures, GV, EQT, IQT and others.
... |
| 17.06.2026 | Odyssey raises $310M at $1.45B valuation to transform AI model simulation | Odyssey, an artificial intelligence lab building world models, today announced it has raised $310 million in early-stage funding at a $1.45 billion valuation.
Natural Capital led, and Amazon.com Inc., AMD Ventures, GV, EQT, IQT and others a... |
| 17.06.2026 | Odyssey Raises $310 Million To Accelerate World Simulation | Odyssey announced that it has raised $310 million in Series B funding at a $1.45 billion valuation to accelerate the development and deployment of its world model technology. The round was led by Natural Capital, with participation from Ama... |
| 17.06.2026 | AI lab Odyssey valued at $1.45 billion in latest funding round | Synopsis
AI lab Odyssey has secured $310 million in a funding round. This investment values the company at $1.45 billion. Natural Capital led the Series B round. Amazon, AMD Ventures, GV, EQT, and IQT also participated. Odyssey is developin... |
| 04.06.2026 | MokN Secures $15M to Revolutionize Identity Theft Protection | MokN secured $15 million in Series A funding. GV led the investment. The cybersecurity firm targets rampant identity theft. Its "Active Identity Recovery" platform offers proactive defense. Funds will fuel US and UK expansion. Mok... |
| 30.05.2026 | MokN Raises $15 Million In Series A Funding To Scale Active Identity Recovery Platform | MokN, a cybersecurity company focused on protecting organizations against credential theft, announced it has raised $15 million in Series A funding. The round was led by GV, with participation from Datadog, Moonfire, OVNI Capital, and angel... |
| 29.05.2026 | Signos: $20 Million Raised To Scale FDA-Cleared CGM System For Weight Management | Signos, the company behind the first FDA-cleared over-the-counter continuous glucose monitoring (CGM) system designed for weight management, announced a $20 million funding round backed by GV (Google Ventures), Dexcom, and Blue Cross Blue S... |
| 29.05.2026 | MokN raises $15M Series A to grow identity theft protection platform | MokN, a French cybersecurity company focused on protecting organisations from credential theft and identity-based attacks, has raised $15 million in Series A funding. The round was led by GV, marking Google Ventures’ first investment in a F... |
| 19.05.2026 | Recursive Superintelligence Ignites AI Race with $650M Funding | Recursive Superintelligence launched with $650M at $4.65B. The startup aims to build self-improving AI. It focuses on AI systems that enhance their own capabilities. This process targets autonomous scientific discovery. GV, Greycroft, Nvidi... |
| 15.05.2026 | Flick Raises $6M Seed Funding | Flick, a San Francisco, CA-based provider of an AI-native filmmaking platform, raised $6M in Seed funding.
Backers included True Ventures, GV (Google Ventures), Y Combinator, Lightspeed, Formosa Capital, Pioneer Fund, Olive Tree Capital, an... |
| 15.05.2026 | Nectar Social Raises $30M in Series A Funding | Nectar Social, Palo Alto, CA-based provider of an agentic social operating solution, raised $30M in Series A funding.
The round was led by Menlo Ventures and its Anthology Fund, created in partnership with Anthropic, with participation from... |
| 15.05.2026 | Recursive Superintelligence Raises $650M in Funding At $4.65 Billion Valuation | Recursive Superintelligence, a London, United Kingdom and San Francisco, CA-based developer of self-improving artificial intelligence software and autonomous training systems, raised $650m in funding round at a $4.65 billion valuation.
The ... |
| 14.05.2026 | Nectar Social: $30 Million Series A Raised For Agentic Marketing Operating System | Nectar Social announced it raised a $30 million Series A round led by Menlo Ventures and its Anthology Fund, which was created in partnership with Anthropic. The round also included participation from True Ventures, GV, and Kinship Ventures... |
| 14.05.2026 | Flick: $6 Million Raised For AI-Native Filmmaking Platform | Flick, an AI-native filmmaking platform founded by Zoey Zhang and Ray Wang, announced it has raised $6 million in seed funding. The round included backing from True Ventures, GV, Y Combinator, Lightspeed, Formosa Capital, Pioneer Fund, Oliv... |
| 14.05.2026 | Recursive: $650 Million Raised At $4.65 Billion Valuation For Self-Improving AI Research | Recursive, a new artificial intelligence research company founded by former leaders from OpenAI, Google DeepMind, Meta AI, Salesforce AI, and Uber AI, announced it is emerging from stealth with a mission to develop self-improving AI systems... |
| 13.05.2026 | Isomorphic Labs Secures $2.1 Billion for AI Drug Discovery Global Scale | Isomorphic Labs secured a massive $2.1 billion in Series B funding. This capital injection accelerates its world-leading AI drug design engine, IsoDDE. The company expands globally, fast-tracking its therapeutic pipeline. Isomorphic aims to... |
| 13.05.2026 | Isomorphic Labs Raises $2.1 Billion Series B To Scale AI Drug Design Engine And Advance Therapeutic Pipeline | Isomorphic Labs, the London-based AI-first drug design and development company, has raised $2.1 billion in Series B funding to accelerate its evolution from pioneering novel AI models to applying them at scale. The round is led by Thrive Ca... |
| 13.05.2026 | Recursive Superintelligence emerges from stealth with $650M raise | A London-based AI startup set up just months ago, which believes it’s pursuing the fastest path to surpassing human intelligence, has today come out of stealth, having raised over $650m at a $4.65bn valuation.
Called Recursive Superintellig... |
| 13.05.2026 | Recursive Superintelligence raises $650M to build self-improving AI models | Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding.
Alphabet Inc.’s GV fund and Greycroft led the round. They were joined by Nvidia Co... |
| 13.05.2026 | Isomorphic Labs lands $2.1BN investment | Sir Demis Hassabis has hailed a multi-billion-dollar investment in the startup he founded which was spun out of Google DeepMind and focuses on leveraging AI to help drug discovery as a “massive vote of confidence”.
Isomorphic Labs said it h... |
| 13.05.2026 | DeepMind CEO Demis Hassabisâ Isomorphic Labs raises $2.1 billion led by Thrive Capital | Synopsis
AI-driven drug discovery firm Isomorphic Labs secured a massive $2.1 billion in Series B funding. This capital will fuel the expansion of their AI drug design engine and advance therapeutic candidates. The investment underscores st... |
| 12.05.2026 | Cerevance Completes Enrollment in Pivotal Phase 3 Parkinson’s Disease Trial and Closes Oversubscribed $20 Million Series C to Extend Runway into 2027 | Boston – MAY 12, 2026 – Cerevance, a clinical-stage biopharmaceutical company advancing targeted therapies for neurodegenerative diseases and obesity, today announced completion of patient enrollment in the pivotal Phase 3 ARISE trial evalu... |
| 12.05.2026 | Google-backed Isomorphic raises $2.1 billion to scale AI-driven drug discovery | May 12 : Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised $2.1 billion in its latest funding round led by existing investor Thrive Capital.
The funding round, completed at an undiscl... |
| 12.05.2026 | Isomorphic Labs secures $2.1 Billion funding to scale its AI drug design engine | Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline.
LONDON, May 12, 2026 /PRNewswire/ -- Isomorphic Labs, an AI-first drug design and d... |
| 07.05.2026 | MOTHER.tech Raises $15M in Total Funding | MOTHER.tech, a NYC-based AI-native creative studio, raised $15M in total funding.
Backers included Google Ventures (GV), Lerer Hippeau Ventures, Box Group, and Shine Capital.
The company intends to use the funds to launch Degen, a new AI-po... |
| 06.05.2026 | Fathom Secures Strategic Investment From CVS Health Ventures For Autonomous Medical Coding Platform | Fathom, an AI-powered autonomous medical coding company, announced a strategic investment from CVS Health Ventures, the venture capital arm of CVS Health, to accelerate the adoption of enterprise-wide autonomous coding across healthcare org... |
| 06.05.2026 | Sierra: $950 Million Raised At $15 Billion Valuation For AI Customer Experience Platform | Sierra announced it has raised $950 million from new and existing investors led by Tiger Global and GV at a valuation exceeding $15 billion.
The company said the new financing brings Sierra’s total capital raised to more than $1 billion, wh... |
| 06.05.2026 | Fathom Secures Strategic Investment from CVS Health Ventures to Scale Autonomous Medical Coding | What You Should Know
Fathom, a leader in autonomous medical coding, has announced a strategic investment from CVS Health Ventures.
The funding follows a period where revenue cycle management (RCM) has become the top priority for health IT i... |
| 06.05.2026 | Built by Lawyers, Tailored by You: Harvey Launches Purpose-Built Legal Agents Across Every Major Practice Area | SYDNEY, May 6, 2026 /PRNewswire/ -- Today, Harvey announced that 500+ use case Agents are live in the platform alongside the company's Agent Builder tool in early access. These pre-built agents cover common legal workflows out of the box wh... |
| 05.05.2026 | MOTHER.Tech Raises $15 Million And Launches Degen, A One-Tap AI Creative App | MOTHER.Tech, an AI-native creative studio based in Brooklyn, has launched Degen, a mobile app that allows users to generate images, videos, memes, carousels, and text content in a single tap without prompt engineering, model management, or ... |
| 30.04.2026 | Iterative Health: $77 Million Raised To Scale Multispecialty Clinical Research Network Powered By AI | Iterative Health, a healthcare technology and services company accelerating clinical research, has closed a $77 million Series C financing round led by Intrepid Growth Partners and GV (Google Ventures), joined by new investors EDBI, an arm ... |
| 30.04.2026 | Firstsource Partners with Typeface to Launch Agentic Marketing Services | New full-stack offering turns content operations into an agentic growth engine
NEW YORK and MUMBAI, India, April 30, 2026 /PRNewswire/ -- Firstsource Solutions Limited (NSE: FSL) (BSE: 532809), an RP-Sanjiv Goenka Group company, today annou... |
| 28.04.2026 | Harvey and Ansarada Partner to Deliver Secure, AI-Powered Deal Workflows | New partnership enables legal and professional services teams to move seamlessly and securely from virtual data room to legal AI-powered analysis.
SYDNEY, April 28, 2026 /PRNewswire/ -- Harvey, the leading AI platform for legal and professi... |
| 27.04.2026 | Omni Secures $120M to Redefine AI Analytics Landscape | Omni secured a massive $120 million Series C funding round. The investment pushes its valuation to $1.5 billion. This capital injection reinforces Omni’s position in the artificial intelligence analytics market. The platform revolutionizes ... |
| 23.04.2026 | Omni raises $120M round backed by GV for its AI analytics platform
Send us a News Tip
EXTRACT THE SIGNAL FROM THE NOISE
Cookies | Omni Analytics Inc. today announced that it has closed a $120 million funding round at a $1.5 billion valuation, more than double what it was valued at last year.
ICONIQ led the Series C investment. It was joined by Alphabet Inc.’s GV ventu... |
| 23.04.2026 | What AI model should you use for revenue intelligence? Von says all the big ones, and it will automate mixing and matching for you | Looking at enterprise AI adoption, VentureBeat has anecdotally observed a fairly wide divergence when it comes to specific roles: For those who build—engineers and developers—the arrival of AI has been transformative, moving through the wor... |
| 23.04.2026 | Omni: $120 Million Series C Raised At $1.5 Billion Valuation For AI Analytics Platform | Omni announced it has raised $120 million in a Series C funding round at a $1.5 billion valuation, led by ICONIQ with participation from Theory Ventures, First Round Capital, Redpoint Ventures, and GV. The round includes a $30 million emplo... |
| 16.04.2026 | Wealth.com Raises $65M in Series B Funding | Wealth.com, a Phoenix, AZ-based provider of an AI-powered platform helping wealth management firms deliver estate and tax planning, raised $65M in Series B funding.
Backers included new investors Titanium Ventures, Pruven Capital, The K Fun... |
| 06.04.2026 | Stipple Bio Raises $100M in Series A Financing | Stipple Bio, Inc., a Cambridge, MA-based biotechnology company leveraging epitope-level precision to create targeted cancer therapies, closed a $100m Series A financing.
The round was co-led by RA Capital, a16z Bio+Health and Nextech Invest... |
| 06.04.2026 | Beacon Biosignals Raises $11M; Brings Series B Financing to Over $97M | Beacon Biosignals, a Boston, MA-based company leveraging brain data to advance human health, raised an $11m extension to its Series B financing, bringing the funding round to $97m the cumulative funding to over $132m.
The upsized round incl... |
| 02.04.2026 | Censys Fuels AI-Driven Cybersecurity Growth with $70 Million Capital Infusion | Censys, a leader in internet intelligence, successfully secured $70 million in strategic funding. This substantial capital injection dramatically accelerates its global platform expansion and the development of advanced AI-driven security s... |
| 01.04.2026 | Censys: $70 Million Raised To Expand Internet Intelligence Platform And AI Security Capabilities | Censys announced that it has raised $70 million in strategic funding to accelerate the expansion of its Internet intelligence platform and advance AI-driven security solutions. The financing includes a $40 million Series D equity round alon... |
| 31.03.2026 | Censys Raises $70M in Strategic Funding | Censys, an Ann Arbor, MI-based company developing solutions to threat hunting and proactive incident response, raised $70M in strategic funding.
The round, consisting of $40M Series D round and $30M debt financing, was led by Morgan Stanley... |
| 27.03.2026 | Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ) | Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
Fri, Mar 27, 2026 08:00 CET Report this content
The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Annual Ge... |
| 26.03.2026 | Sift: $42 Million Series B Raised To Build AI Infrastructure For Mission-Critical Machines | Sift has raised $42 million in Series B funding to expand its platform for AI-driven hardware systems. The round was led by StepStone, with participation from GV, Riot Ventures, Fika Ventures, and CIV, bringing the company’s total funding t... |
| 25.03.2026 | Sift Raises $42M Series B Funding | Sift, an El Segundo, CA-based provider of a intelligence layer service for mission-critical machines, raised $42M in Series B funding.
The round was led by StepStone with participation from GV (Google Ventures), Riot Ventures, Fika Ventures... |
| 21.03.2026 | Biotech Powerhouse Mestag Therapeutics Secures $40M for Advanced Therapies | Mestag Therapeutics has secured $40 million in new financing. This pushes its total funding past $95 million. The Cambridge-based biotech fuels its Phase 1 STARLYS clinical trial for cancer drug MST-0312. This pivotal trial begins in mid-20... |
| 17.03.2026 | Mestag Therapeutics: $40 Million Raised To Advance Fibroblast Immunology Cancer Therapies Into Clinic | Mestag Therapeutics, a biotech company focused on fibroblast immunology, has announced the closing of a $40 million financing round, bringing its total funding to more than $95 million. The round was backed by SV Health Investors, Johnson &... |
| 17.03.2026 | Mestag Therapeutics Raises $40M in Financing | Mestag Therapeutics, a Cambridge, UK-based biotech company harnessing fibroblast immunology to develop treatments for cancer and inflammatory diseases, closed a $40m financing.
Backers includwed SV Health Investors, Johnson & Johnson, t... |
| 13.03.2026 | Healthcare's Digital Lifeline: AI Battles Financial Strain and Revolutionizes Care | Healthcare confronts a severe financial crisis. Innovative AI, particularly agentic platforms, provides vital solutions. Translucent secured $27M to revolutionize hospital finance, offering real-time insights to combat margin leakage and pr... |
| 12.03.2026 | Translucent raises $27M to help healthcare firms automate financial visibility
Send us a News Tip
EXTRACT THE SIGNAL FROM THE NOISE
Cookies | Translucent AI Inc., which provides financial visibility for hospitals and clinics, announced today it has raised $27 million in early-stage funding to bring its AI-native platform to healthcare organizations.
Spending in healthcare was pro... |
| 12.03.2026 | Translucent: $27 Million Raised For AI Healthcare Finance Platform | Translucent, an AI platform focused on healthcare finance, announced it has raised $27 million in a Series A funding round led by GV, with continued participation from NEA, Virtue, and FPV Ventures. The round comes only months after the com... |
| 11.03.2026 | Armadin Secures Record $190M for AI Hyperattack Defense | Armadin, led by Mandiant founder Kevin Mandia, secured a record $190 million in seed and Series A funding. This marks the largest such round in cybersecurity history. The AI-native platform combats "hyperattacks" — machine-speed, ... |
| 11.03.2026 | HIMSS26 Wednesday Wrap-Up: Scaling Agentic AI, Securing the Enterprise, and Fixing Hospital Finance | Wednesday at HIMSS26 brought a necessary, pragmatic reality check to the AI fervor. As the initial hype of massive product launches settles, Day 3 conversations pivoted heavily toward the hard logistics of making these advanced systems actu... |
| 11.03.2026 | Introducing the first Frontier Suite built on Intelligence + Trust | - |
| 11.03.2026 | Translucent Raises $27M in Series A Funding | Translucent, a NYC-based provider of an AI platform for healthcare finance, raised $27M in Series A funding.
The round was led by GV (Google Ventures), with participation from NEA, Virtue, and FPV Ventures.
The company intends to use the fu... |
| 11.03.2026 | Translucent Secures $27M for Healthcare Finance AI Platform | What You Should Know
The Funding: Translucent, an AI-native healthcare finance startup, has closed a $27M Series A funding round led by GV (Google Ventures), with continued participation from NEA, Virtue, and FPV Ventures. This oversubscrib... |
| 10.03.2026 | Kevin Mandia’s Armadin raises record $189.9M to develop AI-driven cyberattack simulation software
Send us a News Tip
EXTRACT THE SIGNAL FROM THE NOISE
Cookies | Artificial intelligence-native cybersecurity company Armadin Inc. announced today that it has raised a cybersecurity industry-record $189.9 million in seed and Series A funding to expand engineering and research teams, further develop the A... |
| 10.03.2026 | Armadin: $189.9 Million Raised For AI-Native Cybersecurity Platform Built To Counter Hyperattacks | Armadin, an AI-native cybersecurity company focused on preparing organizations for the rise of machine-speed cyber threats, announced it has raised $189.9 million in combined seed and Series A funding. The round was led by Accel, with parti... |
| 10.03.2026 | Kevin Mandia sold his cybersecurity company to Google in 2022. He has a fresh $190 million for a new venture | Mandiant founder Kevin Mandia raised $190 million for his AI cybersecurity startup Armadin.
The financing comes four years after Google bought Mandiant for $5.4 billion, with some of the new money coming from the company that acquired his b... |
| 09.03.2026 | SolveAI Raises $50M in Series A Funding | SolveAI, a London, UK–based startup developing an AI powered enterprise coding platform, raised $50m in Pre-Seed and Series A funding.
The total included:
a $45m Series A led by Google Ventures, with participation from Northzone, Mantis VC,... |
| 05.03.2026 | Nvidia прекращает инвестировать в OpenAI и Anthropic перед их выходом на биржу | Миллиардер и частный акционер Tesla Лео Когуан сделал крупную покупку — 1 млн акций Nvidia, оцениваемых примерно в $180 млн, в то время как сама компания сообщила о завершении всех новых инвестиций в OpenAI и Anthropic.
Mariia Shalabaieva, ... |
| 28.02.2026 | In first quarter, $100 M Presight-Shorooq AI Fund invested in five AI startups | Since it launched in September 2025, The Presight-Shorooq Fund I, a $100 million global AI innovation fund, has invested in five cutting-edge AI startups led by experienced alumni from DeepMind, Google X, Meta, and Stanford across the U.S. ... |
| 27.02.2026 | Basis Secures $100M, Valued at $1.15B Amid Accounting Crisis | Basis, an innovative AI agent platform, just secured a massive $100 million in Series B funding. This propels its valuation to $1.15 billion. The company directly confronts the acute talent crisis gripping the accounting profession. Its sop... |
| 26.02.2026 | Basis Secures $100M: AI Agents Transform Accounting at $1.15B Valuation | AI accounting pioneer Basis clinched $100M in Series B funding. This investment propels its valuation to $1.15 billion. The NYC-based firm deploys sophisticated AI agents. These agents automate complex accounting workflows: tax, audit, advi... |
| 25.02.2026 | SambaNova Raises $350M in Series E Financing | SambaNova, a San Jose, CA-based AI infrastructure company, raised over $350m in strategic Series E financing.
The round was led by Vista Equity Partners and Cambium Capital, with participation from Intel Capital, as well asew investors Assa... |
| 25.02.2026 | Basis Raises $100M in Series B Funding | Basis, a NYC-based provider of an AI agent platform for accountants, raised $100M in Series B funding, at $1.15 Billion valuation.
The round was led by Accel, with participation from GV, Lloyd Blankfein, Khosla Ventures and other existing i... |
